Navigation MenuRealWire Limited

Delivering Relevance, Releasing Influence



ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO

ERT have elected current MD Joel Morganroth as CEO until the position is filled permanently. The news of this appointment was covered by Pharmaceutical Business Review, a site that covers the latest pharmaceutical industry news. Pharmaceutical Business Review’s coverage provides ERT with extensive reach to the pharmaceutical industry enabling their appointment story to be read by a large proportion of pharmaceutical professionals and analysts.   


EditorialPharmaceutical Business Review

RealWire Influence Rating2 star

ERT names interim CEO
Pharmaceutical Business Review is a site providing latest pharmaceutical news, comment and industry information it also offers content that is produced by a dedicated team of journalists and global industry experts. In addition to the free content made available on the sites an intelligence store will provides users with market analysis reports from global suppliers of market research and industry analysis.